true

BD® GuardIVa™ Antimicrobial Hemostatic IV Dressing

A care solution for IV, CVC, PICC and percutaneous devices

Background Image
BD® GuardIVa™ Antimicrobial Hemostatic IV Dressing

Ready to learn more? Let’s have a conversation.

Loading
Overview

Chlorhexidine-impregnated sponge dressings are recommended for temporary short-term catheters in patients older than 2 months of age when adherence to basic preventative measures has been unsuccessful

true
Features and Benefits

3 sizes to select from

Each GuardIVa™ Antimicrobial Hemostatic IV Dressing has a consistent disk diameter of 1" (2.5 cm), and is available in 3 sizes of varying hole diameters (1.5 mm, 4 mm and 7 mm), enabling you to use it for a variety of IV, CVC, PICC and percutaneous devices.

Hemostasis

Wound healing efficacy

The GuardIVa™ Antimicrobial Hemostatic IV Dressing demonstrated a wound healing rate nearly double that of Biopatch™ during in vivo testing.†,1 It also has the sufficient CHG amount to provide antimicrobial protection while not inhibiting wound healing.1

Healing

99.99% reduction in bacteria

In vitro testing showed that the GuardIVa™ Antimicrobial Hemostatic IV Dressing reduces 9 microorganisms by 4 log or 99.99%, 
and provides up to 7 days of sustained antimicrobial efficacy within the dressing.*,**2,3

Antimicrobial

Up to 7x less blood loss indicated for surface bleeding

In vivo testing showed that wounds treated with the GuardIVa™ Antimicrobial Hemostatic IV Dressing had up to 7 times less surface blood loss compared to those treated with gauze dressings alone, and significantly reduced time to hemostasis.

 

Ready to learn more?

BD® GuardIVa™ Antimicrobial 
Hemostatic IV Dressing
Ready to learn more? Let’s have a conversation.
Reference

1 Warnings: Do not use the GuardIVa™ Dressing on patients with a known sensitivity to chlorhexidine gluconate. The use of chlorhexidine gluconate containing products has been reported to cause irritation, sensitization, and generalized allergic reactions. If any such reactions occur, discontinue use of the dressing immediately, and if severe, contact a physician.

2 CDC Guidelines, 2011, pg 14. Category 1B

3 Data on file. Bard Access Systems, Inc., Salt Lake City, Utah. Animal study results may not be indicative of clinical performance

INDICATIONS FOR USE:

The GuardIVa™ Antimicrobial Hemostatic IV Dressing is intended for use as a hydrophilic wound dressing to absorb exudate, cover and protect catheter sites. Common applications include IV catheters, other intravenous catheters and percutaneous devices. It is also indicated for control of surface bleeding from percutaneous catheters and vascular access sites.

WARNINGS:

Do not use the GuardIVa™ Dressing on patients with a known sensitivity to chlorhexidine gluconate. The use of chlorhexidine gluconate containing products has been reported to cause irritation, sensitization, and generalized allergic reactions. If any such reactions occur, discontinue use of the dressing immediately, and if severe, contact a physician.

For external use only. Do not allow this product to contact ears, eyes, mouth or mucous membranes.

PRECAUTION:

GuardIVa™ Dressing is not intended to treat infection.

Please consult product labels, IFU, and package inserts for any indications, contraindications, hazards, warnings, cautions, and instructions for use.

true

*The Dressing is not clinically tested for its activity to reduce local infections, catheter-related bloodstream infections (CRBSIs) and skin colonization of microorganisms commonly related to CRBSI.

**Animal study results may not be indicative of clinical performance.
In vivo testing may not be indicative of clinical results.

IV: Intravenous; CVC: Central Venous Catheter; PICC: Peripherally Inserted Central Catheter.

References:
  1. BioPharm - Evaluation of GuardIVa for Haemostatic Properties in Rabbits, 2010.
  2. AATC Method 100 Antimicrobial Efficacy Report, 2010.
  3. GuardIVa 510K Device Description, 2010.

BD-112985 (08/24)

Products & Accessories
Sort by:
Resources